CC
BCLI

Clearline Capital’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Clearline Capital’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,546
Closed -$208K – 42
2017
Q4 		$208K Buy
+3,546
New +$208K 0.11% 46